Experic Secures Growth Investment from 1315 Capital
Experic, a prominent US-based contract development and manufacturing organization (CDMO), recently made headlines with a substantial growth capital investment led by 1315 Capital. This investment is poised to significantly propel Experic's capabilities and expand its services within the global biopharmaceutical industry.
The Significance of the Investment
This new capital injection will empower Experic to enhance its innovative manufacturing capabilities, bolster its international expansion, and uphold its commitment to delivering high-quality services tailored to the biopharmaceutical sector. As the industry evolves, this partnership with 1315 Capital will ensure that Experic is well-equipped to meet the increasing demands for advanced drug development, manufacturing, and clinical trial supply solutions.
Quotes from Leadership
Experic’s CEO and Chairman, David Wood, expressed enthusiasm about joining the 1315 Capital portfolio. He stated, “The firm’s deep expertise in healthcare and proven track record for strategic investments align with our vision for Experic’s growth and expansion of technical capabilities.” Wood emphasized that this investment enables them to continue offering innovative solutions while expanding their global reach in the biopharma market.
Market Demand for Specialized Partnerships
Matt Reber, Partner at 1315 Capital, highlighted the rising trend among biopharmaceutical companies to seek specialized partners. He noted, “Experic’s differentiated expertise, including its unique capability in handling low dose powders and a customer-oriented approach, meets a growing market need.” This collaboration is expected to enhance Experic’s capabilities and extend their global footprint.
About Experic
Experic stands as a noteworthy CDMO, dedicated to providing comprehensive development and manufacturing services tailored to pharmaceutical and biopharmaceutical companies. Their renowned innovative capabilities and customer-focused approach allow them to deliver a wide array of services aimed at expediting the development and commercialization of groundbreaking therapies. This includes addressing various packaging and formulation needs, particularly in dry powder inhalation products.
Commitment to Quality and Speed
At the heart of Experic’s operations is a commitment to quality and efficiency. Their state-of-the-art cGMP facilities enable them to manage the global delivery of high-quality products, even for expedited projects, ensuring that clients receive unparalleled expertise and customer service.
About 1315 Capital
1315 Capital is a distinguished private investment firm managing over $1 billion in assets, specializing in providing growth capital to healthcare services, pharmaceuticals, and medical technology sectors. With a focus on both minority and majority investments, 1315 Capital targets companies with exceptional management teams who can rapidly scale their operations into significant businesses benefiting patients and healthcare providers alike.
Future Outlook
The partnership between Experic and 1315 Capital is a strategic move designed to enhance the capabilities and market reach of Experic in the biopharmaceutical landscape. As the demand for specialized services in drug development and manufacturing continues to surge, this collaboration places Experic in a strong position to lead and innovate in this vital sector.
Frequently Asked Questions
What is the primary focus of the investment from 1315 Capital?
The investment is aimed at enhancing Experic's manufacturing capabilities and supporting its international expansion in the biopharmaceutical industry.
Who is the CEO of Experic?
David Wood serves as the CEO and Chairman of Experic, overseeing its strategic growth and operational excellence.
What separates Experic from its competitors?
Experic’s unique capabilities, especially in handling low-dose powders and providing personalized service, distinguish it in the biopharmaceutical contract development space.
What does CDMO stand for?
CDMO stands for Contract Development and Manufacturing Organization, which provides outsourced services focused on biopharmaceutical and pharmaceutical industries.
How can I learn more about Experic's services?
For more information about Experic and its offerings, interested parties can visit their official website.
